Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27091-27100 Newer>

The Motley Fool November 5, 2007 Billy Fisher	Still Fit at Cigna Earnings growth continues for the insurer, complemented by a big buyback in the third quarter.
The Motley Fool November 5, 2007 Brian Orelli	Last Look at Mini-Mylan An impending merger with Merck's KGaA's generic drug business should more than double revenue at Mylan.
The Motley Fool November 5, 2007 Sham Gad	If You Invest, Go It Alone If you have decided that investing is the route for you, there are a few basics that will enhance your ability to take advantage of the market. The most important one is this: Use available resources, but do your own work.
The Motley Fool November 5, 2007 Anders Bylund	3 Stocks That Missed the Mark These companies overpromised and underdelivered: Rambus... Silicon Motion... ExxonMobil...
The Motley Fool November 5, 2007 Ron Vlieger	Oshkosh on the Road Again Truck manufacturer Oshkosh's merger with construction equipment maker JLG seems to be working; the company announced sales nearly double the previous year's pre-merger totals.
The Motley Fool November 5, 2007 Rick Aristotle Munarriz	You Can't Always Have It Your Way Burger King has another strong quarter, but weighs itself down with a secondary offering.
The Motley Fool November 5, 2007 Brian Lawler	Encysive in a No-Win Situation Encysive Pharmaceuticals needs help to get its lead drug onto the U.S. market in time to turn its financials around. Investors, take note.
The Motley Fool November 5, 2007 Tom Taulli	Investors Turn Down SoundBite On-demand software company SoundBite Communications struggles in its Nasdaq IPO debut.
The Motley Fool November 5, 2007 Emil Lee	3 Ways to Fix Citigroup Citibank's shares are currently at a five-year low. What should the company do to unleash its underlying potential?
The Motley Fool November 5, 2007 Rich Smith	Mulling Masco's Valuation Home-improvement products maker Masco performs better than expected in the third-quarter. With low valuation and a hefty dividend, this is a stock to take a look at.
<Older 27091-27100 Newer> Return to current articles.